BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23748468)

  • 1. Measuring North Carolina pharmacists' support for expanded authority to administer human papillomavirus vaccines.
    Richman AR; Swanson RS; Branham AR; Partridge BN
    J Pharm Pract; 2013 Dec; 26(6):556-61. PubMed ID: 23748468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
    Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations.
    Dingman DA; Schmit CD
    Public Health Rep; 2018; 133(1):55-63. PubMed ID: 29257933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of the characteristics of pharmacist-based immunization services in North Carolina: results of a pharmacist survey.
    Kummer GL; Foushee LL
    J Am Pharm Assoc (2003); 2008; 48(6):744-51. PubMed ID: 19019803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
    Trogdon JG; Shafer PR; Shah PD; Calo WA
    Vaccine; 2016 Aug; 34(38):4514-4519. PubMed ID: 27496275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery.
    Holder NA; Katzenellenbogen R; Middleman AB
    J Adolesc Health; 2013 Sep; 53(3):423-5. PubMed ID: 23830089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utah pharmacists' knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation.
    Tolentino V; Unni E; Montuoro J; Bezzant-Ogborn D; Kepka D
    J Am Pharm Assoc (2003); 2018; 58(4S):S16-S23. PubMed ID: 29739667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns.
    Koskan A; Vizcaino M; Brennhofer SA; Lee CD; Roberto AJ
    Hum Vaccin Immunother; 2021 Sep; 17(9):3090-3095. PubMed ID: 33886423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.
    Dempsey AF; Zimet GD; Davis RL; Koutsky L
    Pediatrics; 2006 May; 117(5):1486-93. PubMed ID: 16651301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus: a brief overview and recommendations for pharmacists.
    Nielsen AR; Hayney MS
    J Am Pharm Assoc (2003); 2014; 54(5):558-61. PubMed ID: 25216887
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California.
    Almeida CM; Tiro JA; Rodriguez MA; Diamant AL
    Vaccine; 2012 Apr; 30(19):3003-8. PubMed ID: 22326776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. North Carolina family practice physicians' perceptions of pharmacists as vaccinators.
    Welch AC; Ferreri SP; Blalock SJ; Caiola SM
    J Am Pharm Assoc (2003); 2005; 45(4):486-91. PubMed ID: 16128505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
    Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
    Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
    Kollar LM; Kahn JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons.
    Malloy KM; Ellender SM; Goldenberg D; Dolan RW
    JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1037-42. PubMed ID: 23989246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Nigerian pharmacists towards pharmaceutical care.
    Oparah AC; Eferakeya AE
    Pharm World Sci; 2005 Jun; 27(3):208-14. PubMed ID: 16096889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the perceptions and administration of the human papillomavirus vaccine.
    Schnatz PF; Humphrey K; O'Sullivan DM
    J Low Genit Tract Dis; 2010 Apr; 14(2):103-7. PubMed ID: 20354417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.